US Broker Ratings

Castle Biosciences, Inc. (CSTL) Stock Analysis: A Healthcare Innovator with Strong Buy Ratings and 9.13% Upside Potential

Castle Biosciences, Inc. (NASDAQ: CSTL) stands out in the healthcare sector, specifically within the diagnostics and research industry. Based in Friendswood, Texas, and boasting a market capitalization of $1.23 billion,..

Prothena Corporation plc (PRTA) Stock Analysis: Evaluating a Potential 96.65% Upside

Prothena Corporation plc (NASDAQ: PRTA), a biotechnology company based in Dublin, Ireland, is gaining attention in the healthcare sector with a notable potential upside of nearly 96.65% according to analyst..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: Exploring a Potential 23% Upside in the Biotech Sector

Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a clinical-stage biotechnology company, has been making waves in the biotech sector with its innovative approach to treating severe autoimmune and inflammatory diseases. With a..

Celcuity Inc. (CELC) Stock Analysis: Exploring the Biotechnology Innovator’s Growth Potential

Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company, stands at the forefront of developing targeted therapies for the treatment of solid tumors. With a market capitalization of $5.13 billion, Celcuity..

Owens & Minor, Inc. (OMI): Investor Outlook Reveals 94% Potential Upside Amidst Challenging Valuation

Owens & Minor, Inc. (NYSE: OMI), a pivotal player in the U.S. healthcare landscape, operates within the medical distribution industry, focusing on providing comprehensive healthcare solutions. Despite its longstanding history..

Kamada Ltd. (KMDA) Stock Analysis: Exploring a 62.91% Upside Potential in the Healthcare Sector

Kamada Ltd. (NASDAQ: KMDA), an Israeli-based biopharmaceutical company, is capturing attention in the healthcare sector with its robust portfolio of plasma-derived protein therapeutics and a promising 62.91% potential upside. As..

AtaiBeckley Inc. (ATAI) Stock Analysis: A Biotech Gem with Over 200% Upside Potential

AtaiBeckley Inc. (NASDAQ: ATAI), a burgeoning player in the biotechnology sector, has captured the attention of investors with its robust pipeline and promising financial outlook. Specializing in mental health treatments,..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: 74% Potential Upside Sparks Investor Interest

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is making waves in the biotechnology sector, not just for its innovative approach to cancer resistance therapies but also for its impressive potential upside. With..

Autolus Therapeutics plc (AUTL) Investor Outlook: Exploring a Potential 511.84% Upside

For investors seeking high-risk, high-reward opportunities in the biotech sector, Autolus Therapeutics plc (NASDAQ: AUTL) offers a fascinating proposition with its substantial potential upside of 511.84%. As a clinical-stage biopharmaceutical..

Abivax SA (ABVX): Investor Outlook on Potential 23.51% Upside and Growing Analyst Confidence

Abivax SA (ABVX), a promising player in the biotechnology sector, has caught the attention of investors with a potential upside of 23.51%, driven by strong analyst confidence and strategic advancements..

Delcath Systems, Inc. (DCTH) Stock Analysis: A 103% Upside Potential in Medical Devices

Delcath Systems, Inc. (NASDAQ: DCTH), a prominent player in the healthcare sector, is garnering significant attention from investors due to its compelling growth potential and unique position in the medical..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Growth Potential Amidst Valuation Challenges in the Medical Device Sector

Avanos Medical, Inc. (NYSE: AVNS) stands at a pivotal point in the medical device industry, offering a diversified portfolio of products aimed at improving patient outcomes. Headquartered in Alpharetta, Georgia,..

Akso Health Group (AHG) Stock Analysis: A 415% Revenue Surge Amidst Valuation Challenges

Akso Health Group (NASDAQ: AHG), an intriguing player in the healthcare sector, has captured investor attention with an impressive 415.80% revenue growth. Despite this standout figure, the company’s financial metrics..

Precigen, Inc. (PGEN) Stock Analysis: Exploring a Potential 75% Upside in the Biotech Sector

Investors with an appetite for high-risk, high-reward opportunities might find Precigen, Inc. (NASDAQ: PGEN) an intriguing prospect. This biopharmaceutical company, rooted in the United States and operating in the dynamic..

Cronos Group Inc. (CRON) Stock Analysis: Navigating Potential Amid a Volatile Cannabis Market

Cronos Group Inc. (NASDAQ: CRON), a prominent player in the burgeoning cannabis industry, presents both intriguing opportunities and palpable challenges for individual investors. Based in Stayner, Canada, Cronos is primarily..

Immatics N.V. (IMTX) Investor Outlook: Exploring an 88% Upside Potential in Biotech

Immatics N.V. (NASDAQ: IMTX) is capturing the attention of individual investors with its focus on pioneering therapies in the biotechnology sector. Headquartered in Tübingen, Germany, this clinical-stage biopharmaceutical company is..

Syndax Pharmaceuticals, Inc. (SNDX) Stock Analysis: Enormous Potential with 89% Upside Amidst Robust Revenue Growth

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is making waves in the biotechnology industry with its cutting-edge therapies aimed at treating cancer. As a commercial-stage biopharmaceutical company, Syndax is not only capturing..

Cullinan Therapeutics, Inc. (CGEM): Investor Outlook with 134% Potential Upside

Cullinan Therapeutics, Inc. (CGEM), a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, has caught the attention of investors with its promising pipeline and substantial upside potential. Specializing in therapies for..

Oruka Therapeutics, Inc. (ORKA)

⚠️ No article content returned.

..

InMode Ltd. (INMD) Stock Analysis: Exploring a 17.9% Potential Upside in the Medical Devices Sector

InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector specializing in medical devices, has garnered attention for its innovative approach to aesthetic treatments. As an Israeli-based company, InMode..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds